Checkpoint Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Checkpoint Therapeutics

04/11/2021 22:40

* Checkpoint Therapeutics Inc  CKPT.OQ  reported a quarterly
adjusted loss of 14 cents​​ per share for the quarter ended in
September. The mean expectation of five analysts for the quarter
was for a loss of 14 cents per share.
* Revenue rose 3.6% to $29.00 thousand from a year ago; 
analysts expected $120.00 thousand. 
* Checkpoint Therapeutics Inc's reported EPS for the quarter was
a loss of 14 cents​.
* The mean earnings estimate of analysts had fallen by
about 13.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Checkpoint Therapeutics Inc shares had risen by 29.1% this
quarter and gained 60.8% so far this year.
* The company reported a quarterly loss of $11.27 million.
* Wall Street's median 12-month price target for Checkpoint
Therapeutics Inc is $17.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 4 at 10:40 p.m.
 ​All figures in US dollars unless otherwise stated